Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Surg Oncol. 2011 May 1;103(6):464-7. doi: 10.1002/jso.21749.

Cancer therapy based on oncogene addiction.

Author information

  • UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94158-9001, USA. mccormick@cc.ucsf.edu

Abstract

Tumor cells contain multiple mutations, yet they often depend on continued expressed of a single oncoprotein for survival. Targeting these proteins has led to dramatic responses. Unfortunately, patients usually progress, through drug resistance or adaptive resistance through reprogramming of signaling networks. The Ras-MAPK pathway provides examples of these successes and failures, and has revealed unexpected degrees of oncogene addiction and signaling complexity that are likely to be useful lessons for the future of targeted therapy.

Copyright © 2011 Wiley-Liss, Inc.

PMID:
21480237
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk